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The kinetic parameters in vitro of the components of
the phosphoenolpyruvate:glycose phosphotransferase
system (PTS) in enteric bacteria were collected. To ad-
dress the issue of whether the behavior in vivo of the
PTS can be understood in terms of these enzyme kinet-
ics, a detailed kinetic model was constructed. Each over-
all phosphotransfer reaction was separated into two el-
ementary reactions, the first entailing association of the
phosphoryl donor and acceptor into a complex and the
second entailing dissociation of the complex into de-
phosphorylated donor and phosphorylated acceptor.
Literature data on the Km values and association con-
stants of PTS proteins for their substrates, as well as
equilibrium and rate constants for the overall phospho-
transfer reactions, were related to the rate constants of
the elementary steps in a set of equations; the rate con-
stants could be calculated by solving these equations
simultaneously. No kinetic parameters were fitted. As
calculated by the model, the kinetic parameter values in
vitro could describe experimental results in vivo when
varying each of the PTS protein concentrations individ-
ually while keeping the other protein concentrations
constant. Using the same kinetic constants, but adjust-
ing the protein concentrations in the model to those
present in cell-free extracts, the model could reproduce
experiments in vitro analyzing the dependence of the
flux on the total PTS protein concentration. For model-
ing conditions in vivo it was crucial that the PTS protein
concentrations be implemented at their high in vivo val-
ues. The model suggests a new interpretation of results
hitherto not understood; in vivo, the major fraction of
the PTS proteins may exist as complexes with other PTS
proteins or boundary metabolites, whereas in vitro, the
fraction of complexed proteins is much smaller.
In many bacteria, the phosphoenolpyruvate:glycose phos-
photransferase system (PTS)1 is involved in the uptake and
concomitant phosphorylation of a variety of carbohydrates (for
reviews, see Refs. 1 and 2). The PTS is a group transfer path-
way; a phosphoryl group derived from phosphoenolpyruvate
(PEP) is transferred sequentially along a series of proteins to
the carbohydrate molecule. The sequence of phosphotransfer is
from PEP to the general cytoplasmic PTS proteins enzyme I
(EI) and HPr and, in the case of glucose, further to the carbo-
hydrate-specific cytoplasmic IIAGlc, membrane-bound IICBGlc
(the glucose permease), and glucose. For other carbohydrates,
specific enzymes II exist (with the A, B, and C domains present
either as a single polypeptide or as multiple proteins, depend-
ing on the carbohydrate that is transported), which accept the
phosphoryl group from HPr (1–4).
Apart from its direct role in the above phosphotransfer and
its indirect role in transport, IIAGlc is an important signaling
molecule, mediating catabolite repression (reviewed in Refs. 1,
2, and 5). The presence or absence of a PTS substrate affects
the IIAGlc phosphorylation state; in the absence of PTS sub-
strate, phosphorylated IIAGlc predominates, which activates
adenylate cyclase and hence increases the intracellular cyclic
AMP level, thereby affecting the expression of a large number
of genes. The presence of a PTS substrate, on the other hand,
will lead to dephosphorylation of IIAGlc. Unphosphorylated
IIAGlc can bind stoichiometrically to the uptake systems for
some non-PTS substrates for growth, inhibiting these uptake
systems allosterically by so-called “inducer exclusion” and pre-
venting the entry of the alternative carbon substrates into the
cell to induce their own catabolic genes.
The individual components of the PTS have been character-
ized extensively, using kinetic and structural approaches (for a
review, see Refs. 1, 2, 3, and 4). In the kinetic analysis of the
PTS proteins, many Km values for their substrates and prod-
ucts, as well as the equilibrium constants of the phosphotrans-
fer reactions have been determined. A recent development is
the direct determination, using a rapid quench method, of the
forward and reverse rate constants of phosphotransfer between
HPr and IIAGlc of Escherichia coli (6).
Metabolic control analysis is a quantitative framework de-
veloped by Kacser and Burns (7) and Heinrich and Rapoport (8)
for describing the steady-state behavior of metabolic systems
and the dependence of cellular variables (e.g. fluxes or inter-
mediate concentrations) on parameters (e.g. enzyme concentra-
tions). The intracellular concentrations of all four glucose PTS
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proteins in Salmonella typhimurium (9) and of IICBGlc in E.
coli (10) have been modulated in turn to determine the extent
to which each of these proteins controls the PTS-mediated
uptake rate in vivo. These dependences were quantified with
so-called flux response coefficients, defined as the percentage
change in the uptake rate upon a 1% increase in the enzyme
concentration (see “Appendix” for mathematical definitions).
Furthermore, titrations with different amounts of E. coli cell-
free extracts (11) have enabled the quantification of the extent
to which the glucose PTS proteins together control PTS-medi-
ated phosphorylation activity in vitro at different protein con-
centrations. There was a remarkable difference between the
results obtained in vitro and in vivo; in vivo, the four flux
response coefficients added up to 0.8 (9), whereas in vitro, this
sum varied between 1.5 and 1.8 depending on the total protein
concentration (11). A value of greater than unity for this sum is
in itself remarkable, since it reflects a higher order than linear
dependence of flux on total protein concentration and contrasts
strongly with the linear relationship between reaction rate and
enzyme concentration usually found in enzyme kinetics. How-
ever, following these experiments, two additional questions are
still unresolved. (a) What is the cause of the discrepancy be-
tween the sum of the flux response coefficients of the PTS
proteins in vivo and in vitro, and why does this sum vary in
vitro as the protein concentration changes? (b) Metabolic con-
trol analysis of group transfer pathways predicts that the sum
of the enzyme flux response coefficients should lie between 1
and 2 (12). In vivo, this sum is less than 1; however, the flux
response coefficients toward PEP, pyruvate, and glucose were
not determined (9). Is it reasonable to assume that this sum
increases to values above 1 if flux responses toward these
“boundary metabolites” are included?
To address these questions and to determine whether such
different behavior under conditions in vivo and in vitro may
realistically be expected from the same metabolic system, we
constructed a detailed kinetic model of the PTS in enteric
bacteria, using literature data to assign values to the rate
constants of the elementary phosphotransfer reactions. The
results of steady-state calculations with the model are com-
pared with experimental data, and the difference between ex-
perimental behavior of the PTS in vivo and in vitro is proposed
to be the result of a novel aspect, i.e. the formation of long living
transition state complexes between the different PTS proteins
and the bound phosphoryl group.
The PTS may well be regarded as a paradigm for what has
been termed “nonideal” metabolism (13). It is a group transfer
pathway with special control properties (12); it is a perfect
mechanistic example of metabolic channeling and therefore
affected by macromolecular crowding (11); it is involved in
signal transduction through catabolite repression and inducer
exclusion (see above); and a similar sequence of phosphoryl
transfer is ubiquitous in the “two-component regulatory sys-
tems” (14, 15), which have been proposed to form an intracel-
lular “phosphoneural network” (16). Any attempt at a deeper
understanding of such cellular processes at a level beyond map
making, component identification, and characterization will
have to put the pieces of the puzzle together in a quantitative
“systems framework.” This paper is such an attempt.
MATERIALS AND METHODS
Calculation of Rate Constants for Elementary Steps—A phospho-
transfer reaction from a phosphoryl donor AP to an acceptor E can be
symbolized as follows.
E 1 APL|;
kI
k2I
EP 1 A
SCHEME 1
We shall use Roman numerals as subscripts to designate the rate
constants for such an overall phosphotransfer reaction; the forward rate
constant is kI, and the reverse rate constant is k2I, yielding an equilib-
rium constant Keq of kI/k2I. This overall reaction can be divided further
into two elementary reactions, the first involving association of E and
AP into the complex EPA, and the second involving dissociation of the
complex into EP and A as follows.
E 1 APL|;
k1
k21
EPAL|;
k2
k22
EP 1 A
SCHEME 2
Scheme 2 has four elementary rate constants, i.e. the forward and
reverse rate constants of both the association and dissociation reac-
tions, which will be denoted by subscripted arabic numerals. Scheme 2
is an extended description of Scheme 1, and in general the two will not
be valid simultaneously. However, if the concentration of the interme-
diate complex EPA is assumed to be constant because its rate of pro-
duction equals its rate of consumption (i.e. assuming a steady state for
EPA), both reaction Schemes 1 and 2 are valid descriptions of the same
process, and their rate constants can be related (see below).
We calculated the values of the rate constants for Scheme 2 from
experimental data. Four types of data were available: (a) equilibrium
constants for phosphotransfer reactions, (b) Km values of some enzymes
for their substrates or products, (c) association or dissociation equilib-
rium constants for some enzymes and substrates or products, and (d)
rate constants of the type kI and k2I for the overall phosphotransfer
reactions (Scheme 1).
First, the equilibrium constant was expressed as a function of the
rate constants of the elementary steps as follows.
Keq 5
kI
k2I
5
k1k2
k21k22
(Eq. 1)
Second, Km values were related to the individual rate constants. Reac-
tion Scheme 2 differs from that of a traditional enzyme in that the
catalyst does not return unaltered. Only after EP has transferred its
phosphoryl group to another molecule in additional reactions, free E is
returned; also, the regeneration of AP requires additional reactions.
Hence, the meaning of the Michaelis constant is also different. We
applied the method analogous to that of Briggs-Haldane (17) by writing
the differential equations and equating the time derivative of [EPA] to
zero. This then allowed us to write rate equations for the zero product
and the zero substrate case, which had the same form as the Michaelis-
Menten equation. Hence, the Km values of the “enzyme” E for AP and A
(denoted with an asterisk to indicate this difference, i.e. KmAP
* and
KmA
* ) are defined as follows.
K*mAP 5
k21 1 k2
k1
(Eq. 2)
and
K*mA 5
k21 1 k2
k22
(Eq. 3)
The operational meaning of KmAP
* is the concentration of AP giving
half-maximal rates when both [EP] and [A] are negligible; that of KmA
*
is the concentration of A giving half-maximal reverse rates at zero [AP]
and [E].
Third, association or dissociation equilibrium constants of enzymes
and substrates or products were expressed in terms of rate constants of
the elementary steps. Dissociation/association equilibrium constants of
AP and A in Scheme 2 are given by the following.
KdAP 5
1
KaAP
5
k21
k1
(Eq. 4)
and
KdA 5
1
KaA
5
k2
k22
(Eq. 5)
It may be noted that the former Ka refers to the association to E,
whereas the latter Ka refers to the association to EP.
Fourth, we related the rate constants of the overall phosphotransfer
reactions (Scheme 1) to those where the complex was included explicitly
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(Scheme 2). By following a steady-state treatment (18) for the complex
EPA, one can derive the following.
kI 5
k1k2
k21 1 k2
(Eq. 6)
and
k2I 5
k21k22
k21 1 k2
(Eq. 7)
Using the approaches outlined in Equations 1–7, a set of four independ-
ent equations was generated for each phosphotransfer reaction of the
PTS, relating the kinetic parameters Km
* , Kd, Ka, Keq, kI, and k2I to the
elementary rate constants. The equations were solved simultaneously
for the rate constants of the elementary steps on the basis of experi-
mental values of the kinetic parameters. The derivations of the elemen-
tary rate constants for the five phosphotransfer reactions of the glucose
PTS are given under “Appendix.”
Reaction Scheme 2 may be divided further by including the step
E z PA º EP z A explicitly, yielding three elementary steps in total.
However, we did not consider this case, since insufficient data were
available to assign values to all the rate constants in such a mechanism.
Model Parameters—To simulate the reactions of the PTS numeri-
cally, a few parameters other than the rate constants of the elementary
reactions are required: the total concentration of each PTS protein and
the concentrations of the boundary metabolites PEP, pyruvate, glucose
(or methyl a-D-glucopyranoside (MeGlc), its nonmetabolizable ana-
logue), and glucose 6-phosphate (or MeGlc 6-phosphate). The subunit
molecular masses of the cytoplasmic PTS proteins EI (63,489), HPr
(9109), and IIAGlc (18,099) (19) were used to calculate intracellular
concentrations of 5 mM (EI monomers), 20–100 mM (HPr), and 20–60 mM
(IIAGlc) from the intracellular amounts of these proteins reported in the
literature (20–23). An intracellular volume of 2.5 ml/mg dry mass (24–
26) was assumed in the calculations. Because IICBGlc is a membrane
protein, intracellular amounts were reported on the activity level. In-
tracellular IICBGlc amounted to 10 mmol/liter cytoplasmic volume, as
calculated from the specific activity of the protein and the glucose
phosphorylation activity of E. coli given in Ref. 27.
For E. coli growing exponentially on glucose, intracellular PEP levels
of 60–300 mM (28, 29) and pyruvate levels of 0.36–8 mM (28, 30) have
been reported. These PEP values may underestimate the intracellular
concentration, due to the long filtration time (up to 60 s) employed by
the authors for sampling (see discussion in Ref. 31). Furthermore,
transport assays in our laboratory are routinely performed with
washed, concentrated, and starved cell suspensions (32). Under these
conditions, intracellular PEP and pyruvate levels have recently been
determined for glucose-grown E. coli; the PEP concentration was 2.8
mM, and that of pyruvate was 0.9 mM (33). We used these values for our
simulations of PTS uptake assays. The MeGlc concentration was set to
500 mM, a concentration used routinely for uptake assays. Intracellular
MeGlc 6-phosphate was fixed at 50 mM. During PTS-mediated carbohy-
drate uptake, intracellular carbohydrate phosphates will accumulate,
their concentrations increasing from initial values close to zero when
the substrate is a nonmetabolizable analogue. Numerical simulation of
the PTS requires, however, that the boundary metabolite concentra-
tions be fixed; otherwise, calculation of a steady state will be impossible.
The chosen low MeGlc 6-phosphate concentration reflects the situation
during the initial stages of the uptake process; in addition, we verified
that increasing this value to 6 mM had negligible effect (less than 0.1%)
on the observed flux (at 6 mM Glc zP, the dissociation of IICBGlc z P z Glc
into IICBGlc and Glc z P should be .99% irreversible; cf. “Appendix”).
When simulating PTS-mediated phosphorylation in vitro, the rate
constants of the elementary steps were left unchanged. The dilution of
the cytoplasmic proteins in our cell-free extracts in comparison to the
intracellular environment was accounted for by calculating a dilution
factor from the protein concentration of our extract and the reported
intracellular total protein concentration of 0.25 g/ml (34). The intracel-
lular concentrations of the PTS proteins were multiplied by this dilu-
tion factor to calculate their concentrations in the cell extract. Concen-
trations of the boundary substrates PEP, pyruvate, MeGlc, and MeGlc
6-phosphate were entered as employed under the experimental
conditions.
All parameter values of the kinetic model are summarized in Table I.
Concentrations of the PTS proteins and of the boundary metabolites are
shown for the simulation of PTS activity in vivo and at two protein
concentrations in vitro.
Numerical Methods—Simulations and steady-state calculations of
the kinetic models were performed on an IBM-compatible personal
TABLE I
Parameters of the kinetic model
Parameters Units In vivo
In vitro
2 mg of
protein/ml 6 mg of protein/ml
PTS protein concentrations
[EI]total mM 5 0.04 0.12
[HPr]total mM 50 0.4 1.2
[IIAGlc]total mM 40 0.32 0.96
[IICBGlc]total mM 15 0.12 0.36
Boundary metabolite concentrations
PEP mM 2800 4000 12,000
Pyruvate mM 900 0 0
MeGlc mM 500 10,000 10,000
MeGlc 6-P mM 50 0 0
Rate constants (PTS step in parentheses)
k1 (PEP to EI) mM
21 min21 1960a
k21 (PEP to EI) min21 480,000
k2 (PEP to EI) min
21 108,000
k22 (PEP to EI) mM
21 min21 294
k3 (EI to HPr) mM
21 min21 14,000
k23 (EI to HPr) min
21 14,000
k4 (EI to HPr) min
21 84,000
k24 (EI to HPr) mM
21 min21 3360
k5 (HPr to IIA
Glc) mM21 min21 21,960
k25 (HPr to IIA
Glc) min21 21,960
k6 (HPr to IIA
Glc) min21 4392
k26 (HPr to IIA
Glc) mM21 min21 3384
k7 (IIA
Glc to IICBGlc) mM21 min21 880
k27 (IIA
Glc to IICBGlc) min21 880
k8 (IIA
Glc to IICBGlc) min21 2640
k28 (IIA
Glc to IICBGlc) mM21 min21 960
k9 (IICB
Glc to Glc) mM21 min21 260
k29 (IICB
Glc to Glc) min21 389
k10 (IICB
Glc to Glc) min21 4800
k210 (IICB
Glc to Glc) mM21 min21 5.4 3 1023
a Identical values were used for the rate constants under all conditions.
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computer with the metabolic modeling program SCAMP (35). The cal-
culations were checked with Gepasi (36).
Parameter Sensitivity Analysis—To determine the sensitivity of the
kinetic model to the choices made for the kinetic parameters, we calcu-
lated the flux response coefficients with respect to those parameters (for
details see “Appendix”). The flux response coefficient of a parameter
was a measure of the sensitivity of the steady-state flux to changes in
that specific parameter.
RESULTS
Here, we shall describe the kinetic behavior of the model and
compare this to experimental results obtained in vivo and in
vitro. Furthermore, a parameter sensitivity analysis will be
presented to determine to what extent the results depended on
assumptions that were made during the derivation of the rate
constants of the elementary steps from the phenomenological
kinetic constants measured experimentally (see “Appendix”).
Steady-state Behavior—The steady-state flux predicted by
the enzyme kinetic parameters of the PTS is shown in Table II
for simulation of a PTS uptake assay in vivo and a phospho-
rylation experiment in vitro at two different protein concentra-
tions. The corresponding experimental values are for compar-
ison. For the modeled flux, agreement between model and
experiment was good; although the modeled value was always
lower than the experimental value, the discrepancy was only
approximately 30% (i.e. less than a factor of 2) for conditions in
vivo and in vitro. This discrepancy is small considering the fact
that the calculation was based exclusively on experimentally
determined parameters; no parameter value was fitted.
Next, we investigated whether the model would match ex-
perimental data obtained by varying the concentrations of the
PTS proteins. The effect of changing in turn the concentrations
of EI, HPr, IIAGlc, and IICBGlc on PTS uptake activity (while
keeping enzyme concentrations other than the modulated one
constant) has been determined experimentally (9); these exper-
iments were mimicked by numerical simulation. First we con-
sidered small variations, expressing the results in terms of
response coefficients (i.e. the percentage change in flux for a 1%
increase in enzyme concentration). Table II shows that the
calculated response coefficients matched their experimental
counterparts remarkably well.
A reservation concerning the use of response coefficients is
that they refer to small parameter changes, whereas in biolog-
ically relevant cases, changes may well exceed 50%. We there-
fore also considered large variations in enzyme concentrations.
Again the simulation results agreed remarkably well with ex-
perimental data: the modeled flux versus PTS protein concen-
tration profiles matched the experimental ones (Fig. 1). An
exception was the decrease in PTS uptake activity for high EI
levels (9), which was not observed in the simulations. Fig. 1
also shows that changing the concentrations of EI, HPr, and
IIAGlc around their wild-type levels had little effect on the flux;
this was quantified by calculating the flux response coefficients
of these proteins, as indicated on the graphs. The flux response
coefficients of IIAGlc and IICBGlc were slightly higher than the
experimentally reported values (cf. Table II).
A kinetic model will gain credibility if it can describe exper-
imental data in vivo as well as in vitro without the need for
adjustment of the kinetic parameters. The effect of concomitant
changes in the concentrations of all proteins of the glucose PTS
on its phosphorylation activity in vitro has been investigated
experimentally by performing a PTS activity assay with differ-
ent amounts of cell extract (11). We mimicked these experi-
ments by numerical simulation (Fig. 2). As was observed ex-
perimentally (Figs. 1 and 2 in Ref. 11), the dependence of the
flux on total protein concentration was more than linear but
less than quadratic (Fig. 2a). Accordingly, the combined PTS
flux response coefficient (RPTS
J ) decreased from almost 2 to
around 1.7 as the protein concentration was increased from low
values to 6 mg/ml (Fig. 2b).
In previous experiments, the macromolecular crowding
agent PEG 6000 (37, 38) has been added to a PTS activity assay
to mimic high intracellular macromolecule concentrations, and
its effect was simulated with a simple kinetic model (11). We
now proceeded to model macromolecular crowding with the
complete model of the PTS by following a similar approach as
in Ref. 11; the addition of PEG 6000 to the assay mixture was
assumed to increase the on-rate constants for complex forma-
tion between the proteins and decrease the off-rate constants
for complex dissociation by the same factor, a. Comparing Fig.
2 with Fig. 1, a and b, in Ref. 11, we see that the model agreed
well with the experimental results; the addition of 9% PEG
6000 (simulated by a 5 7) stimulated the flux slightly at low
protein concentrations and inhibited the flux at higher protein
concentrations. A lower concentration (4.5%) of PEG 6000 (sim-
ulated by a 5 4) stimulated the flux over the whole range of
protein concentrations. As was the case with PEG 6000 addi-
tion experimentally, the combined flux response coefficient
RPTS
J decreased more sharply in the model when the parameter
a was increased (Fig. 2b); the decrease was sharper for 9% PEG
6000 and a 5 7 than for 4.5% PEG 6000 and a 5 4.
Metabolic control analysis of group transfer pathways has
provided us with an analytical proof that the sum of the flux
response coefficients of the proteins in a group transfer path-
way can range from below 1 to 2 (12) and that values closer to
1 can result from increased complex formation between the
proteins or a protein and a boundary metabolite. The absence of
these complexes, on the other hand, leads to a value of 2 for this
sum (39). As has been pointed out under “Discussion” of Ref. 11,
decreasing RPTS
J values with increasing protein concentration
TABLE II
Steady-state properties of the kinetic model and comparison with experimental values
The flux J, the flux response coefficients of the four glucose PTS proteins, and their sum RPTS
J were calculated with the parameter set of
Table I for conditions in vivo and in vitro at two protein concentrations. RIIA
J and RIICB
J refer to the flux response coefficients with respect to the
total concentrations of IIAGlc and IICBGlc, respectively.
Steady-state
variable
In vivo In vitro
Model Experimenta
2 mg of protein/ml 6 mg of protein/ml
Model Experimentb Model Experimentb
J (mM min21) 1.4 3 104 2.2 3 104 13 18 97 144
REI
J 0.05 0 0.07 NDc 0.07 ND
RHPr
J 20.02 #0.01 0.08 ND 0.05 ND
RIIA
J 0.2 #0.02 0.9 ND 0.7 ND
RIICB
J 0.9 0.7 0.9 ND 0.9 ND
RPTS
J 1.1 0.7–0.8 1.9 2.0 1.7 1.7
a Experimental data from Ref. 9.
b Experiments performed as in Ref. 11, except that glucose was used as carbon source for the cultivation of E. coli PJ4004.
c ND, not determined.
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suggest increased complex formation between the proteins of
the PTS. We investigated this point further by calculating with
the kinetic model, using parameter values simulating in vivo
and values simulating in vitro at protein concentrations of 2
and 6 mg/ml (Table I), the fraction of the different PTS proteins
that was free (uncomplexed) and the fraction that was com-
plexed with other proteins or boundary metabolites (Table III).
For each condition, the concentrations of all the species and
their relative proportions are indicated. The kinetic parame-
ters implied that the major fraction of the PTS proteins should
exist in the complexed state in vivo (Table III). This was in
accordance with the RPTS
J value close to 1 (Table II). Simulating
conditions in vitro showed that the fraction of the proteins that
existed in the complexed state was much lower but increased
significantly with an increase in the protein concentration from
2 to 6 mg/ml. We also verified that increasing the parameter a
to mimic macromolecular crowding caused a further increase in
the fraction of PTS proteins existing in the complexed state
(data not shown).
Parameter Sensitivity Analysis—Of course, the kinetic pa-
rameters used in the derivation of the rate constants (see
“Appendix”) were subject to experimental variability. In addi-
tion, insufficient data were available in some cases to calculate
the rate constants from the kinetic parameters, and assump-
tions had to be made (e.g. Equation 21). To establish how
strongly the behavior of the model depended on the choices for
the kinetic parameters, the sensitivity of the steady-state flux
under conditions in vivo to changes in these parameters was
calculated as outlined under “Appendix.” The sensitivity of the
calculated flux to an uncertainty in a parameter value is quan-
tified by the corresponding response coefficient.
The flux response coefficients of all model parameters (when
simulating conditions in vivo) are listed in Table IV. In general,
the flux response coefficients were small, indicating that the
calculated flux did not depend crucially on the absolute mag-
nitude of the chosen parameters, also when the reported liter-
ature values varied over a considerable range (e.g. KmPEP or
KmHPr
* ). Notably, the parameters, the values of which had to be
assumed altogether to solve for the rate constants of phospho-
transfer reactions II–IV (KaII, KaIII, and KaIV), had low flux
response coefficients, which precludes any unusually large un-
certainty in the calculated flux. The only parameters with large
flux response coefficients were KmIIAGlczP
* , kIV, KmGlc, kV, and
[IICBGlc]total (0.5, 0.7, 0.3, 0.3, and 0.9, respectively). This was
not entirely unexpected for the following reasons. First, mod-
ulations in both KmIIAGlczP
* and kIV resulted in an equal relative
change in the rate constant k8 (Equation 40), and the flux
control coefficient of reaction 8 (i.e. from IIAGlc z P z IICBGlc to
IIAGlc and IICBGlc z P) in the model was high (C8
J 5 0.6); sec-
ond, modulations in both KmGlc and kV resulted in an equal
relative change in the rate constant k10 (Equation 48), and the
flux control coefficient of reaction 10 (i.e. from IICBGlc z P z Glc
to IICBGlc and Glc z P) in the model was relatively high (C10
J 5
0.3); third, as shown by theory (12), both a high C8
J and a high
C10
J are consistent with a high RIICB
J ; and finally, IICBGlc was
the only PTS protein in the model with a high flux response
coefficient, in agreement with experimental results (9, 10).
FIG. 1. Dependence of the calculated PTS flux in vivo on the concentrations of the PTS proteins EI, HPr, IIAGlc, and IICBGlc.
Simulations were performed with the kinetic parameters in vivo of Table I. The concentration of each PTS protein was modulated in turn over the
indicated range while keeping the other concentrations at their reference (wild-type) values. This mimics the experiments performed by van der
Vlag and co-workers (Fig. 6 in Ref. 9); these data are included in the figure for reference. Wild-type levels are shown by vertical dotted lines. The
modeled flux J is indicated by a solid line and shown on the left y axis; the modeled flux response coefficient of the respective protein is indicated
by a dotted line and shown on the right y axis. Experimental flux data (9) are indicated by solid circles (raw data) and dashed-dotted lines (fitted
curves from the original paper). EI (a), HPr (b), IIAGlc (c), and IICBGlc (d) concentration profiles are shown.
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DISCUSSION
Experimental metabolic control analysis of the glucose PTS
in vivo (9, 10) and in vitro (11) has yielded many interesting
experimental results and increased our understanding of this
group transfer pathway in particular and of other information
transfer pathways such as the two-component regulatory sys-
tems (15, 16) in general. For example, IICBGlc was the only PTS
protein that controlled MeGlc uptake in vivo to any significant
extent (9, 10), and the combined flux response coefficient of the
glucose PTS proteins in vitro was higher than in vivo and
moreover depended on the protein concentration in the assay,
suggesting that substantial complex formation between the
PTS proteins may occur in vivo (11).
This paper reports on the construction of a detailed kinetic
model of the PTS. The model can describe experimental data
and suggests a new interpretation of results that have not yet
been explained fully, as we shall discuss below. There was good
agreement between model and experiment in vivo, both for flux
values and flux response coefficients (Table II). Furthermore,
the same model parameters could simulate conditions in vitro
(Table II, Fig. 2). The fact that experimental and simulated
RPTS
J values agreed well (Table II) indicates that the degree of
complex formation between the PTS proteins in vitro was mod-
eled correctly. Furthermore, the model shows that the com-
bined PTS flux response coefficient (and hence, the degree of
complex formation between the proteins) can differ markedly
between conditions in vivo and in vitro.
Prior to this study, two questions brought up by experimen-
tal results were still unresolved: first, the discrepancy between
the combined flux response coefficient of the four glucose PTS
proteins in vivo (9) and in vitro (11) had yet to be explained
fully; second, the combined flux response coefficient of 0.8 for
the four glucose PTS proteins in vivo (9) was less than unity,
while theory predicts a value between 1 and 2 when including
flux responses to the boundary metabolites (12).
Both of these issues have essentially been resolved in this
paper. First, the model could calculate different values of RPTS
J
with the same model parameters, depending on whether con-
ditions in vivo or in vitro were simulated. The difference stems
from the higher degree of complex formation between the PTS
proteins in vivo (Table III). Regarding the second issue, a value
of 1.5 was previously derived for RPTS
J when including the
boundary metabolites on the grounds that RMeGlc
J equaled RIICB
J
(9), which would fit with the theoretical prediction. However,
an equality between RIICB
J and RMeGlc
J only holds if no com-
plexes exist between the different PTS proteins or between a
protein and a boundary metabolite (12). Both the present mod-
eling results (Table III) and the experimental determination of
RPTS
J in vitro (11) argue against this assumption, as they sug-
gest that complex formation between the PTS proteins plays an
important role in vivo. Nevertheless, the boundary metabolites
could in principle account for the difference between 0.8 and 1
and increase the combined response coefficient to values be-
tween 1 and 2. Our model, however, does not support this
explanation, since RPEP
J , RPyr
J , RMeGlc
J , and RMeGlcP
J were low
when simulating in vivo conditions (Table IV). A possible rea-
son for a decrease in RPTS
J to values below 1 is the formation of
abortive, noncatalytic complexes between two or more proteins.
For example, IIAGlc has been shown to bind HPr when both
proteins are unphosphorylated (40). Such abortive complexes
were not taken into account in the kinetic model for lack of
detailed knowledge concerning the relevant equilibrium bind-
ing constants.
In constructing the kinetic model, we used kinetic parameters
for glucose and not for MeGlc (its nonmetabolizable analogue),
although MeGlc was used for both the uptake experiments in
vivo (9) and the flux analyses in vitro (11). The reasons for this
were 2-fold. First, there was a large discrepancy between re-
ported Km values for MeGlc (170 mM in vivo and 6 mM in vitro)
whereas the Km values for glucose agreed much better (20 mM in
vivo and 10 mM in vitro) (41). Second, the Kd value, which was
used in the calculations (Equation 43), had only been determined
for glucose (42). The agreement between model and experiment,
also for large ranges of parameter variation (Figs. 1 and 2),
suggests that selecting the parameters for glucose (and not for
MeGlc) was not crucial in the present analysis.
The agreement between model and experiment is even more
significant when one considers that the present model is based
FIG. 2. Dependence of the calculated PTS flux in vitro on the
total protein concentration when increasing all PTS proteins
and PEP together. Simulations were performed with the kinetic pa-
rameters in vitro of Table I. The concentrations of the PTS proteins for
a certain protein concentration were calculated by assuming a total
intracellular protein concentration of 0.25 g/ml, as described under
“Materials and Methods.” The concentration of PEP in mM was set to
twice the protein concentration in mg/ml, corresponding to the experi-
ments in Ref. 11. The addition of the macromolecular crowding agent
PEG 6000 to the assay mixture was simulated by increasing the rate
constants that lead to complex formation between proteins by a factor a
and decreasing the rate constants of protein-protein complex dissocia-
tion by the same factor a (see also Ref. 11). The rate constants for
interactions between a protein and a boundary metabolite were left
unchanged. Thus, k3, k24, k7, and k28 were multiplied by a, and k23, k4,
k27, and k8 were divided by a. The flux J (a) and the combined flux
response coefficient of EI, HPr, IIAGlc, and IICBGlc (RPTS
J ) (b) are shown
as a function of protein concentration for a 5 1, 4, and 7.
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directly on kinetic data. Experimentally determined parameters
taken from the literature were entered in the model; they were
not subject to a fitting procedure. The flux calculated with the
model was generally insensitive to changes in the kinetic param-
eters that were used in the derivation of the kinetic rate con-
stants (Table IV), indicating that our selection of a parameter
from a range of literature values, or the assumption of a value
where no data were available, did not bias the result signifi-
cantly. The high parameter sensitivities toward KmIIAGlczP
* and
kIV (and hence to k8) as well as to KmGlc and kV (and hence to k10)
were in agreement with the suggestion (9), based on the deter-
mination of RIICB
J in vivo, that the flux control coefficients of the
fourth and fifth phosphotransfer reactions (from phosphorylated
IIAGlc to glucose or MeGlc) in vivo are high.
In the construction of the model, we have made some sim-
plifications. First, we did not take into account that EI can
dimerize. The dimer is the active form (43–45); the monomer-
dimer equilibrium depends on PEP, Mg(II) ions, and tempera-
ture, and phosphorylation shifts the equilibrium significantly
to the monomeric state (46, 47). Detailed studies of the mono-
mer-dimer transition (46, 48, 49) have also shown that the
monomer cannot be phosphorylated by PEP, leading to a model
proposing that an active EI dimer is phosphorylated by PEP
and then dissociates into two phosphorylated monomers, which
subsequently pass the phosphoryl group to HPr and redimerize
(1, 50, 51). This cycle was not included in the present kinetic
model, since insufficient data were available on the additional
rate constants involved. Moreover, at EI concentrations pres-
ent in vivo, it should be virtually only dimer. Since there is no
suggestion of cooperativity of the two subunits during phospho-
rylation, we conclude that it is valid to treat EI as a monomer
for the kinetic equations presented in this paper.
Second, IICBGlc, the membrane-bound glucose permease,
has also been shown to exist in dimeric form (52, 53), and
immunoprecipitation experiments have suggested that four
IIAGlc molecules are bound to the IICBGlc dimer (53). We have
not included this phenomenon in the kinetic model either for
lack of kinetic details.
Third, the kinetic model ignores the vectorial nature and
compartmentation of the uptake process. The reactions are
simulated as if they occurred in a well stirred reactor; however,
PTS-mediated uptake entails that extracellular glucose or
MeGlc be taken up and phosphorylated to yield intracellular
glucose 6-phosphate or MeGlc 6-phosphate. For modeling pur-
poses, this should have no consequences, since there are no
extracellular pools of variable metabolites. The extracellular
glucose (or MeGlc) concentration is a fixed parameter, as is the
intracellular glucose 6-phosphate (MeGlc 6-phosphate) concen-
tration; it was not required, therefore, to enter the different
volumes of the extracellular and intracellular compartments in
the model.
A final simplification concerns the organism described. Most
of the kinetic data used in the model are from E. coli, while the
physiological uptake experiments with varying PTS protein
levels were performed on S. typhimurium. Because of the iden-
tity of HPr and near identity of EI and IIAGlc in the two
organisms (2), this should pose no problem. Even the IICBGlc
proteins from both organisms have very similar kinetic prop-
erties despite differences in their isoelectric points and specific
activities (27). In addition, variation of intracellular IICBGlc
levels in E. coli and S. typhimurium leads to very similar
physiological responses (9, 10). We have therefore combined as
much as possible of the available data on both organisms into
a general model of the glucose PTS in enteric bacteria.
Calculations with the kinetic model show that under condi-
tions in vivo the largest proportion of the PTS exists as long
living transition state complexes, either between two PTS pro-
teins and the bound phosphoryl group or between a protein, a
boundary substrate, and the bound phosphoryl group (Table
III). In contrast, under conditions in vitro a much larger frac-
TABLE III
Simulated distribution of PTS protein species under different conditions
Steady-state calculations were performed with the parameters of Table I for conditions in vivo and two protein concentrations in vitro.
Species
In vivo In vitro
Concentration Percentageof total
2 mg of protein/ml 6 mg of protein/ml
Concentration Percentageof total Concentration
Percentage
of total
mM % nM % nM %
EI species
EI z P z Pyr 3.1 61.0 0.12 0.3 0.9 0.7
EI 0.27 5.4 0.01 0.02 0.02 0.02
EI z P 1.2 23.8 39.7 99.3 118 98.3
EI z P z HPr 0.49 9.8 0.16 0.4 1.2 1.0
Total EI 5.0 100 40 100 120 100
HPr species
EI z P z HPr 0.5 1.0 0.2 0.04 1 0.1
HPr 1.3 2.6 27 6.8 67 5.5
HPr z P 30 59.6 364 90.9 1069 89.1
HPr z P z IIAGlc 18 36.9 9 2.2 63 5.2
Total HPr 50 100 400 100 1200 100
IIAGlc species
HPr z P z IIAGlc 18 46.2 9 2.8 63 6.6
IIAGlc 0.6 1.6 26 8.2 63 6.6
IIAGlc z P 15 38.5 280 87.4 798 83.1
IIAGlc z P z IICBGlc 5.5 13.7 5 1.6 37 3.8
Total IIAGlc 40 100 320 100 960 100
IICBGlc species
IIAGlc z P z IICBGlc 5.5 54.7 5.1 6.3 37 15.2
IICBGlc 1.4 14.1 72 90.2 183 76.4
IICBGlc z P 0.1 1.2 0.01 0.01 0.04 0.02
IICBGlc z P z MeGlc 3.0 29.9 2.8 3.5 20 8.4
Total IICBGlc 10 100 80 100 240 100
Proteins in complexes 63 4 10
Proteins uncomplexed 37 96 90
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tion is uncomplexed. This is in agreement with the control
theory (12), which relates RPTS
J values approaching 2 to the
absence of protein-protein complexes and RPTS
J values near 1 to
the prevalence of these complexes in significant proportions. In
fact, complexes between HPr and IIAGlc (40), as well as IIAGlc
and IICBGlc (53) have been demonstrated biochemically, al-
though both proteins were unphosphorylated. It is likely that
their interaction will be much stronger if one of the two pro-
teins is phosphorylated, since this situation obtains during the
normal sequence of phosphotransfer along the PTS. Therefore,
complexes between the PTS proteins may well exist for signif-
icant lifetimes in the cell.
Table III shows that only 1.6% of the total IIAGlc exists in the
free unphosphorylated state when simulating MeGlc uptake in
vivo. The question arises how the PTS can still regulate other
systems by inducer exclusion under these conditions, because
unphosphorylated IIAGlc binds stoichiometrically to its target
proteins. Additional simulations (54) have shown that intro-
duction of a step for binding of free unphosphorylated IIAGlc to
a target protein leads to a redistribution of the IIAGlc forms and
that a significant fraction of the total IIAGlc can bind to the
target protein if the dissociation equilibrium constant is in the
range of 0.2–1 mM, as reported for glycerol kinase and IIAGlc in
the presence of Zn(II) (55). However, the addition of glucose by
itself to a suspension of E. coli cells (i.e. under non-inducer
exclusion conditions) has been shown to lead to .95% dephos-
phorylation of IIAGlc after 15 s (33). How does this relate to the
39% IIAGlczP (i.e. ..5%) calculated by the model when simu-
lating glucose (or MeGlc) uptake in vivo (Table III)? One ex-
planation can certainly be based on the intracellular concen-
trations of PEP and pyruvate, and specifically their ratio,
which drops from 3.0 to less than 0.1 after the cells have been
challenged with glucose for 15 s and recovers to 0.2 after 30 s
(33). Using these PEP and pyruvate concentrations, the model
predicts IIAGlc z P to be 7% of the total IIAGlc 15 s after glucose
addition (14% after 30 s), which agrees much better with the
experimental results. Why did we not use the lower PEP/
pyruvate ratios in our simulations? It is a well known fact that
the PTS-mediated MeGlc uptake rate decreases with time (the
slope of the curve decreases), and to ensure that we simulate
initial uptake rates, we entered the concentrations of PEP and
pyruvate in the model as they were determined just prior to
glucose addition.
The second-order rate constant for phosphotransfer between
HPr and IIAGlc reported by Meadow and Roseman (6) (6.1 3
107 M21 s21) is much larger than the value of 6 3 106 M21 min21
(105 M21 s21) reported by Misset et al. (56). The larger value is
essential for obtaining the results presented here. Using the
lower value of Misset et al., the simulated flux was significantly
lower, and the flux response coefficients of EI and HPr were
significantly higher, which did not match the experimental
results (data not shown). We conclude, therefore, that the use
of the second order rate constant of IIAGlc phosphorylation
reported in Ref. 56 in our kinetic model yielded results that did
not correspond with the strain and conditions used in the
experiments determining the flux response coefficients in vivo
and that the experimental improvement of measuring the
phosphotransfer directly between the two proteins (6) resulted
in values that improved the fit of the model to MeGlc uptake
data in vivo. In contrast, the second order rate constant of EI
phosphorylation by PEP (2 3 108 to 109 M21 min21 5 200–1000
mM21 min21) reported in Ref. 47 agrees very well with the 360
mM21 min21 found by Meadow and Roseman.2
Remarkably, the effects of the macromolecular crowding agent
PEG 6000 on PTS activity in vitro could be simulated with the
kinetic model by assuming increased on-rates for protein-protein
complex formation and decreased off-rates for its dissociation. An
increased relative fraction of complexes between the proteins
could in principle be achieved by increasing the on-rates for
complex formation or by decreasing the off-rates for complex
2 N. D. Meadow and S. Roseman, unpublished results.
TABLE IV
Parameter sensitivity analysis of the kinetic model
Parameter p PTS step Equationa Units Reference value Rp
J b
KmPEP PEP to EI 10 mM 300 3 3 10
22
KmPyr PEP to EI 11 mM 2000 6 3 10
23
KeqI PEP to EI 12 Dimensionless 1.5 4 3 10
22
kI PEP to EI 13 mM
21 min21 360 2 3 1023
K*mHPr EI to HPr 18 mM 7 2 3 10
23
kII EI to HPr 19 mM
21 min21 12,000 7 3 1022
k2II EI to HPr 20 mM
21 min21 480 22 3 1022
KaII EI to HPr 21 mM
21 1 23 3 1023
K*mHPr z P HPr to IIA
Glc 26 mM 1.2 1 3 1022
kIII HPr to IIA
Glc 27 mM21 min21 3,660 8 3 1022
k2III HPr to IIA
Glc 28 mM21 min21 2,820 26 3 1022
KaIII HPr to IIA
Glc 29 mM21 1 26 3 1022
K*mIIAGlc z P IIA
Glc to IICBGlc 34 mM 4 5 3 1021
kIV IIA
Glc to IICBGlc 35 mM21 min21 660 7 3 1021
k2IV IIA
Glc to IICBGlc 36 mM21 min21 240 23 3 1023
KaIV IIA
Glc to IICBGlc 37 mM21 1 23 3 1023
KmGlc IICB
Glc to Glc 42 mM 20 3 3 1021
KdGlc IICB
Glc to Glc 43 mM 1.5 4 3 1026
KeqV IICB
Glc to Glc 44 Dimensionless 5.9 3 105 7 3 1026
kV IICB
Glc to Glc 45 mM21 min21 240 3 3 1021
[EI]total mM 5 5 3 10
22
[HPr]total mM 50 22 3 10
22
[IIAGlc]total mM 40 2 3 10
21
[IICBGlc]total mM 10 9 3 10
21
[PEP] mM 2800 2 3 1022
[Pyruvate] mM 900 25 3 1022
[MeGlc] mM 500 1 3 1022
[MeGlc 6-P] mM 50 27 3 1026
a Equation number where parameter is related to rate constants.
b Flux response coefficients of the parameters (Rp
J) were calculated as described under “Appendix.”
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dissociation or both. Minton (57) has argued on thermodynamic
grounds that the association of monomers to homopolymers
should be stimulated by the addition of crowding agents mainly
via an enhancement of the on-rate. As reasoned in Ref. 11, how-
ever, PEG 6000 resulted in both a stimulation and an inhibition
of the flux, depending on the protein concentration, and this can
only be achieved by a simultaneous effect on both the on-rate and
the off-rate. Indeed, even for the simplistic assumption that the
on-rate and off-rate constants are affected to the same extent (but
in opposite directions) by PEG 6000 addition and furthermore
that complex formation between the different PTS proteins is
enhanced to the same extent, the agreement between model and
experiment was remarkable when comparing the effect of two
PEG 6000 concentrations with two values for the parameter a,
i.e. the factor by which the rate constants are affected (cf. Fig. 1
in Ref. 11 and Fig. 2a in this paper). It may be noted that when
calculating the PTS transport rate in vivo, we set the crowding
parameter a to 1, i.e. implying that we used the concentrations of
PTS proteins on the basis of number of molecules per intracellu-
lar cytoplasmic volume without taking into account the volume
exclusion effects accompanying macromolecular crowding. In
parallel calculations (not shown here), we set a to values different
from 1. The results were closer to experimental observations on
some counts but farther off on others. More in vivo experimental
work is needed; our model may be helpful here.
The comprehensive kinetic model of the PTS presented in
this paper may be used to predict the flux through the PTS for
different induction levels of the glucose PTS proteins. Further-
more, the phosphorylation states of all the proteins (i.e. the
ratio between the phosphorylated and unphosphorylated
forms) can be computed, which has important implications for
signaling (e.g. by IIAGlc in inducer exclusion and the activation
of adenylate cyclase). There is a distinct possibility for improve-
ment and further validation of the model by measuring the
phosphorylation state of IIAGlc under different conditions, as
described in Ref. 33, and comparing the results with the model
predictions. We have used only flux data to assess the perform-
ance of the model in describing experimental results; inclusion
of the concentrations of the phosphorylated and unphosphoryl-
ated protein forms should be an interesting and valuable ad-
dition. We have presented preliminary reports (54) on the use
of the kinetic model to simulate the interaction of the signal
transducer IIAGlc with its target proteins under conditions that
lead to the phenomena of inducer exclusion (2) and reverse
inducer exclusion (58). An ambitious goal is the incorporation
of the present model in a much larger model describing the
glycolysis of enteric bacteria. Realization of such a project
should provide interesting new insights into metabolic regula-
tion, especially since glycolysis following PTS-mediated uptake
differs from that in other organisms in that the phosphoryl
donor for the initial carbohydrate phosphorylation during PTS-
mediated uptake is PEP and not ATP.
The kinetic equations presented here are a first step in
devising a testable model for quantifying sugar uptake by the
PTS, and we have used a particular set of conditions (i.e.
glucose-grown cells) to test the model. However, the model is
adaptable to other experimental conditions, for instance with
cells grown on other carbon sources or with leaky mutant PTS
proteins, provided that the necessary parameters are defined.
Under such conditions, it may well be that PTS proteins other
than IICBGlc become the major rate determinants for sugar
uptake. For instance, in the extreme case, if EI were all mon-
omer or was somehow converted to all monomer, sugar uptake
would halt. The importance of the present model is that it can
readily be adjusted to account for unknown factors that affect
functioning of the PTS as they are characterized and their
kinetic effects are determined in vitro. These factors can in-
clude regulators on the genetic level; e.g. Mlc, a negative reg-
ulator of the ptsHI operon and ptsG, has recently been proposed
to bind to unphosphorylated IICBGlc, so that conditions leading
to IICBGlc dephosphorylation (glucose transport, ptsHIcrr de-
letion) may result in IICBGlc sequestering Mlc, leading to ptsHI
and ptsG activation (59).
Since signal transduction along two-component regulatory
systems (14, 15) involves phosphoryl transfer similar to the
PTS, our modeling results suggest that complex formation be-
tween the different signaling proteins may well be expected to
occur as well. This could strongly influence their control prop-
erties in that the combined flux response, and thus the speed of
signal transmission, depends on macromolecular crowding and
differs between intracellular conditions and dilute solutions in
vitro. Furthermore, this pattern of signal transfer is not limited
to prokaryotes. For example, phosphoryl transfer through the
components of a two-component system was demonstrated to
be part of the osmosensing response in yeast (60). In addition,
a chimeric protein consisting of the sensing domain of the E.
coli aspartate receptor and the cytosolic portion of the human
insulin receptor was able to activate the insulin pathway in
response to aspartate (61), demonstrating the generality of the
signal transfer mechanism. Therefore, the novel aspects of
metabolic behavior described in this paper may also apply to
eukaryotic signal transduction. Most importantly, we show
here how it is possible to analyze these systems quantitatively,
in order to assess their properties and predict their dynamic
behavior in the living cell.
Acknowledgments—We thank Rechien Bader-van’t Hof for perform-
ing PTS phosphorylation assays and Jannie Hofmeyr and Boris
Kholodenko for helpful discussions.
APPENDIX
Metabolic Control Analysis
Metabolic control analysis is a quantitative framework orig-
inally developed by Kacser and Burns (7) and Heinrich and
Rapoport (8) to quantify the control of the steady-state behav-
ior of metabolic systems. An important entity in this analysis is
the so-called flux response coefficient, which quantifies the
extent to which a change in a parameter of a metabolic path-
way affects the flux through that pathway and is defined math-
ematically as follows,
Rpj
J 5 S›J›pjD pk z pjJ 5 S› lnuJu› ln pjD pk (Eq. 8)
where J is the steady-state flux through the pathway and pj is
the modulated parameter. Operationally, Rpj
J can be envisaged
as the percentage change in J upon a 1% increase in pj. The
parameter pj can, for example, be the concentration of an ex-
ternal metabolite that affects the pathway flux or the concen-
tration of an enzyme in the pathway. When measuring a flux
response coefficient, the system is allowed to relax to a new
steady state after perturbation in the parameter pj while keep-
ing all of the other parameters pk constant, as indicated by
subscript pk.
The extent to which any catalytic component (e.g. an elemen-
tary step of a reaction mechanism) controls the flux is quanti-
fied by a control coefficient, which, for a step i of the system, is
defined (62) as follows,
Ci
J 5
~› lnuJu/›pi!pk
~› lnuviu/›pi!sj, pk
(Eq. 9)
where pi is any parameter that affects step i specifically. Sub-
script pk indicates, as above, that the other parameters pk
remain constant and that the entire system relaxes to a new
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steady state after a change in pi; subscript sj, pk indicates that
the change in the rate vi of the independent step i is considered
locally at constant reactant and product concentrations (63).
For step i, referring to an elementary reaction in an enzyme
mechanism (as the individual phosphotransfer reactions of the
PTS), the control coefficient has also been termed the friction
coefficient (64).
Derivation of Rate Constants for PTS Reactions
Here we derive elementary rate constants, as shown in
Scheme 2 under “Materials and Methods,” for the five phospho-
transfer reactions of the glucose PTS from available kinetic
data for the PTS components, using the relationships in Equa-
tions 1–7. In some cases, insufficient data were available, and
additional assumptions had to be made, as indicated clearly. To
ensure that all quantities were expressed in the same units, we
consistently converted all concentrations to micromolar and all
time units to minutes.
Phosphotransfer from Phosphoenolpyruvate to EI—The first
phosphotransfer reaction from PEP to EI can be written sche-
matically as follows,
EI 1 PEPL|;
kI
k2I
EI z P 1 Pyr
SCHEME 3
EI 1 PEPL|;
k1
k21
EI z P z PyrL|;
k2
k22
EI z P 1 Pyr
SCHEME 4
where Scheme 3 shows the direct phosphotransfer and Scheme
4 includes the complex EIzPzPyr explicitly.
Reported Km values of Scheme 4 (i.e. of EI for PEP) range
from 0.2 to 0.4 mM (43, 65), and values of EI z P for Pyr range
from 1.5 to 3 mM (66). Furthermore, the equilibrium constant
for the above reaction is 1.5 (44). Using a rapid quench method
as described in Ref. 6, the forward rate constant of the overall
phosphorylation reaction (i.e. kI in Scheme 3) has been deter-
mined as 6 3 106 M21 s21.3 Selecting values of 0.3 and 2 mM for
KmPEP and KmPyr, respectively, the following set of equations
can be derived using the approaches outlined under “Materials
and Methods.”
KmPEP 5
k21 1 k2
k1
5 300 mM (Eq. 10)
KmPyr 5
k21 1 k2
k22
5 2000 mM (Eq. 11)
KeqI 5
kI
k2I
5
k1k2
k21k22
5 1.5 (Eq. 12)
kI 5
k1k2
k21 1 k2
5 6 3 106 M21s21 5 360 mM21min21 (Eq. 13)
Equations 10–13 can be solved simultaneously for the elemen-
tary rate constants k1, k21, k2, and k22 of Scheme 4 as follows.
k1 5
kI@KeqIKmPEP 1 KmPyr#
KeqIKmPEP
5 1960 mM21min21 (Eq. 14)
k21 5
kIKmPyr
KeqI
5 480,000 min21 (Eq. 15)
k2 5 kIKmPEP 5 108,000 min21 (Eq. 16)
k22 5
kI@KeqIKmPEP 1 KmPyr#
KeqIKmPyr
5 294 mM21min21 (Eq. 17)
Phosphotransfer from EI to HPr—The second phosphotrans-
fer reaction from phosphorylated EI to HPr can be written
schematically as follows.
EI z P 1 HPrL|;
kII
k2II
EI 1 HPr z P
SCHEME 5
EI z P 1 HPrL|;
k3
k23
EI z P z HPrL|;
k4
k24
EI 1 HPr z P
SCHEME 6
Again, the former reaction, Scheme 5, describes direct phos-
photransfer, whereas the latter (Scheme 6) includes the com-
plex EI z P z HPr explicitly.
Reported Km
* values of EI for HPr range from 2.7 to 9 mM (43,
65, 67–69); we shall assume a value of 7 mM here. The associ-
ation constant Ka for EI and HPr is 10
5 M21 (abstract cited in
Ref. 1), although this most probably refers to the interaction
between unphosphorylated EI and HPr. The interaction be-
tween a phosphorylated and an unphosphorylated protein is
likely to be stronger than that between two unphosphorylated
proteins, since the former situation obtains during the normal
phosphotransfer reaction sequence. Recently, the rate con-
stants of the overall phosphorylation reaction (Scheme 5) were
determined directly using the rapid quench method (see above):
kII 5 2 3 10
8 M21 s21 and k2II 5 8 3 10
6 M21 s21.2 The
equilibrium constant for phosphotransfer from EI to HPr, as
calculated from kII and k2II, is 25; this value is higher than the
2.3–8.9 reported previously (44). Because of their direct deter-
mination, we shall use the above values for kII and k2II and 25
for Keq II. The combined equilibrium constant for the first two
PTS reactions (i.e. phosphotransfer from PEP to HPr) is 1.5 3
25 5 37.5 when proceeding from the measured rate constants,
which likewise exceeds the experimental value of 10.8 6 7.7
reported previously (44).
We can derive the following set of equations.
K*mHPr 5
k23 1 k4
k3
5 7 mM (Eq. 18)
kII 5
k3k4
k23 1 k4
5 2 3 108 M21s21 5 12,000 mM21min21 (Eq. 19)
k2II 5
k23k24
k23 1 k4
5 8 3 106 M21s21 5 480 mM21min21 (Eq. 20)
Equations 18–20 contain insufficient information to solve for
the rate constants k3, k23, k4, and k24 unambiguously. Some
additional choice has to be made for k3, k23, or k24. For exam-
ple, fixing the association equilibrium constant Ka of EIzP and
HPr allows calculation of all of the rate constants. We assumed
the association of EIzP and HPr to be 10-fold stronger that that
of unphosphorylated EI and HPr,
KaII 5 k3/k23 5 106 M21 5 1 mM21 (Eq. 21)
This yields the following rate constants for the elementary
steps in Scheme 6.
k3 5
K*mHPrKaIIIkII
K*mHPrKaIII 2 1
5 14,000 mM21min21 (Eq. 22)
k23 5
K*mHPrkII
K*mHPrKaIII 2 1
5 14,000 min21 (Eq. 23)3 N. D. Meadow and S. Roseman, unpublished results.
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k4 5 K*mHPrkII 5 84,000 min21 (Eq. 24)
k24 5 K*mHPrKaIIIk2II 5 3360 mM21min21 (Eq. 25)
Phosphotransfer from HPr to IIAGlc—The third phospho-
transfer reaction from phosphorylated HPr to IIAGlc can be
written schematically as follows.
HPr z P 1 IIAGlcL|;
kIII
k2III
HPr 1 IIAGlc z P
SCHEME 7
HPr z P 1 IIAGlcL|;
k5
k25
HPr z P z IIAGlcL|;
k6
k26
HPr 1 IIAGlc z P
SCHEME 8
As above, Scheme 7 shows the direct phosphotransfer, and
Scheme 8 includes the complex HPr z P z IIAGlc explicitly.
Values of 0.3 mM (69) and 2.7 mM (56) have been reported for
the Km
* of IIAGlc for HPrzP. The association constant Ka for HPr
and IIAGlc was measured as 104 to 105 M21 (40); however, this
was measured for unphosphorylated HPr, not HPrzP. As for the
interaction between EI and HPr, the Ka of HPrzP and IIA
Glc will
most probably be larger than that for unphosphorylated HPr
and IIAGlc because HPrzP donates a phosphoryl group to IIAGlc
during the normal phosphotransfer reaction sequence. The rate
constants for the overall phosphorylation reaction (Scheme 7)
have been published: kIII 5 6.1 3 10
7 M21 s21 and k2III 5 4.7 3
107 M21 s21 (6). The equilibrium constant for phosphotransfer
from HPr to IIAGlc, as calculated from kIII and k2III, is 1.3; this
value is 10-fold higher than the 0.13 reported previously (70).
Assuming a value of 1.2 mM for the Km
* of IIAGlc for HPr z P
and using the directly determined rate constants, we can derive
the following set of equations.
K*mHPr z P 5
k25 1 k6
k5
5 1.2 mM (Eq. 26)
kIII 5
k5k6
k25 1 k6
5 6.1 3 107 M21s21 5 3660 mM21min21 (Eq. 27)
k2III 5
k25k26
k25 1 k6
5 4.7 3 107 M21s21 5 2820 mM21min21 (Eq. 28)
As was the case for phosphotransfer between EI and HPr,
Equations 26–28 contain insufficient information to solve for
the rate constants k5, k25, k6, and k26 unambiguously. We here
assumed additionally a value of 1 mM21 for the association
constant of HPr z P and IIAGlc. This is identical to the associ-
ation constant of EI z P and HPr, and 10–100-fold larger than
the association constant of unphosphorylated HPr and IIAGlc
(see above). With the additional assumption,
KaIII 5 k5/k25 5 1 mM21 (Eq. 29)
and using Equations 26–28, the following rate constants for
the elementary steps in Scheme 8 were calculated.
k5 5
KaIIIkIIIK*mHPr z P
KaIIIK*mHPrzP 2 1
5 21,960 mM21min21 (Eq. 30)
k25 5
kIIIK*mHPr z P
KaIIIK*mHPrzP 2 1
5 21,960 min21 (Eq. 31)
k6 5 kIIIK*mHPr z P 5 4392 min21 (Eq. 32)
k26 5 KaIIIk2IIIK*mHPr z P 5 3384 mM21min21 (Eq. 33)
However, we have reservations about both published values for
K
m HPr z P
* . In order for the assay conditions in the paper by Reizer et
al. (69) to measure the Km of the reaction that the authors claim,
all of the HPr must have been phosphorylated, whereas all of the
IIAGlc must have been dephosphorylated. Whereas the former
condition may well have been true, one cannot assume that the
latter condition always held, because of (a) the speed of the
HPrzP-IIAGlc phosphotransfer reaction and (b) the low concentra-
tions of IICBGlc used in comparison with the higher HPr concen-
trations. In the paper by Misset et al. (56), the fact that no IIAGlc
was added to the assays calls into question just which PTS was
being measured, especially in the light of the structural similar-
ity and functional exchangeability of the IIA domains of various
sugar-specific systems (see e.g. Refs. 71 and 72). For these rea-
sons, we also modeled phosphoryl transfer between HPrzP and
IIAGlc as a direct reaction (Scheme 7), using the published values
of kIII and k2III, and omitting Km HPr z P
* (Equation 26) as well as
the assumption of Ka (Equation 29). The modeling results did not
differ significantly from the ones presented in Figs. 1 and 2 (data
not shown). For reasons of consistency, we therefore modeled all
five phosphotransfer reactions as proceeding via an explicit tran-
sition state complex.
Phosphotransfer from IIAGlc to IICBGlc—The fourth phospho-
transfer reaction from phosphorylated IIAGlc to IICBGlc can be
written schematically as follows.
IIAGlc z P 1 IICBGlcL|;
kIV
k2IV
IIAGlc 1 IICBGlc z P
SCHEME 9
IIAGlc z P 1 IICBGlcL|;
k7
k27
IIAGlc z P z IICBGlcL|;
k8
k28
IIAGlc 1 IICBGlc z P
SCHEME 10
Scheme 9 shows the direct phosphotransfer, and Scheme 10
includes the transition state complex IIAGlczPzIICBGlc explicitly.
The Km
* of IICBGlc for IIAGlczP ranges from 1.7 to 5 mM (22, 69,
70, 73). Recently, the rate constants of the overall phosphoryl-
ation reaction (Scheme 9) were determined directly using the
rapid quench method (see above): kIV 5 1.1 3 10
7 M21 s21 and
k2IV 5 4 3 10
6 M21 s21.3 Using these rate constants and a
value of 4 mM for Km IIAGlczP
* yields three equations.
K*mIIAGlc z P 5
k27 1 k8
k7
5 4 mM (Eq. 34)
kIV 5
k7k8
k27 1 k8
5 1.1 3 107 M21s21 5 660 mM21min21 (Eq. 35)
k2IV 5
k27k28
k27 1 k8
5 4 3 106 M21s21 5 240 mM21min21 (Eq. 36)
No additional literature data were found. In order to solve for the
rate constants k7, k27, k8, and k28, one further independent
equation (i.e. one assumption) is needed as above. We assumed
an association constant of 1 mM21 for IIAGlc z P and IICBGlc (iden-
tical to the association constants of EI z P and HPr and of HPr z P
and IIAGlc). This yielded the following additional equation,
KaIV 5 k7/k27 5 1 mM21 (Eq. 37)
which, together with Equations 34–36, was solved simulta-
neously for the rate constants of the elementary steps in
scheme 10 as follows.
k7 5
KaIVkIVK*mIIAGlc z P
KaIVK*mIIAGlc z P 2 1
5 880 mM21min21 (Eq. 38)
3 N. D. Meadow, R. Savtchenko, and S. Roseman, unpublished
results.
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k27 5
kIVK*mIIAGlc z P
KaIVK*mIIAGlc z P 2 1
5 880 min21 (Eq. 39)
k8 5 kIVK*mIIAGlc z P 5 2640 min21 (Eq. 40)
k28 5 KaIVk2IVK*mIIAGlc z P 5 960 mM21min21 (Eq. 41)
Phosphotransfer from IICBGlc to Glucose—The fifth and final
phosphotransfer reaction from phosphorylated IICBGlc to glu-
cose (Glc) can be written schematically as follows.
IICBGlc z P 1 GlcL|;
kV
k2V
IICBGlc 1 Glc z P
SCHEME 11
IICBGlc z P 1 GlcL|;
k9
k29
IICBGlc z P z GlcL|;
k10
k210
IICBGlc 1 Glc z P
SCHEME 12
As previously, Scheme 11 shows the direct phosphotransfer,
and Scheme 12 includes the complex IICBGlczP z Glc explicitly.
Note that during PTS-mediated uptake, the substrate is phos-
phorylated concomitantly with the uptake process, so that Glc
above refers to extracellular glucose, whereas Glc z P refers to
intracellular glucose 6-phosphate.
The Km of IICB
Glc for glucose is 10 mM in vitro and 20 mM in
an uptake assay in vivo (41). The dissociation constant Kd of
glucose from IICBGlc is 1.5 mM (42). The equilibrium constant
KeqV for Scheme 11 was taken as 5.9 3 10
5. This was calculated
from the equilibrium constant of 107.9 for phosphoryl transfer
along the complete PTS from PEP to glucose (44) and from the
equilibrium constants for each of the other phosphoryl transfer
reactions. The forward overall rate constant of Scheme 11 was
determined recently using the rapid quench method (see
above): kV 5 4 3 10
6 M21 s21.3
It should be noted that the kinetic parameters for glucose
and not for MeGlc (its nonmetabolizable analogue) were used in
this derivation, although MeGlc was used for both the uptake
experiments in vivo (9) and the flux analyses in vitro (11). The
reasons for this were 2-fold. First, there was a large discrep-
ancy between reported K
m
values for MeGlc (170 mM in vivo and
6 mM in vitro) (41), whereas the Km values for glucose agreed
much better (see above). Second, the Kd value (Equation 43)
has only been determined for glucose (42) (also see
“Discussion”).
Using 20 mM for the Km of IICB
Glc for glucose and the KdGlc,
KeqV, and kV values above, the following set of equations,
KmGlc 5
k29 1 k10
k9
5 20 mM (Eq. 42)
KdGlc 5 k29/k9 5 1.5 mM (Eq. 43)
KeqV 5
kV
k2V
5
k9k10
k29k210
5 5.9 3 105 (Eq. 44)
kV 5
k9k10
k29 1 k10
5 4 3 106 M21s21 5 240 mM21min21 (Eq. 45)
was solved simultaneously to calculate the rate constants of the
elementary steps in Scheme 12,
k9 5
kVKmGlc
KmGlc 2 KdGlc
5 260 mM21min21 (Eq. 46)
k29 5
kVKmGlcKdGlc
KmGlc 2 KdGlc
5 389 min21 (Eq. 47)
k10 5 kVKmGlc 5 4800 min21 (Eq. 48)
k210 5
kVKmGlc
KeqVKdGlc
5 5.4 3 1023 mM21min21 (Eq. 49)
Parameter Sensitivity Analysis
The flux response coefficients toward the model parameters
in Table IV were calculated as follows. Consider, as an exam-
ple, RKmPEP
J (i.e. the parameter sensitivity toward KmPEP). From
Equation 8 we have the following,
RKmPEP
J 5 S › lnuJu› ln KmPEPD pk
5 Rk1
J S › ln k1› ln KmPEPD pk 1 Rk21J S › ln k 2 1› ln KmPEPD pk
1 Rk2
J S › ln k2› ln KmPEPD pk 1 Rk 2 2J S › ln k 2 2› ln KmPEPD pk (Eq. 50)
The flux response coefficients Rk1
J , Rk21
J , Rk2
J , and Rk22
J in Equa-
tion 50 were calculated directly by the program SCAMP using
the Fluxsensitivity feature. The other derivatives were calcu-
lated from the expressions for the rate constants derived above.
Consider the first term as an example. From Equation 14 we
have the following.
ln k1 5 ln kI 1 ln@KeqIKmPEP 1 KmPyr# 2 ln KeqI 2 ln KmPEP (Eq. 51)
Differentiating partially,
› ln k1
› ln KmPEP
5 21 1
KeqIKmPEP
KeqIKmPEP 1 KmPyr
5
2KmPyr
KeqIKmPEP 1 KmPyr
5
22000
1.5 3 300 1 2000
5 20.82 (52)
The other derivatives were calculated similarly, enabling de-
termination of the flux response coefficient RKmPEP
J using Equa-
tion 50. The other parameter sensitivities in Table IV were
obtained by following a similar approach.
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